• Questions
  • Tournaments
  • Services
  • News
  • Questions
  • Tournaments
  • Questions
  • Questions
Feed Home
👥
Communities
💎
Metaculus Cup
🤖
Q2 AI Benchmarking
🌍
USAID Outlook
🏛️
POTUS Predictions
💵
Fiscal Showdown
Topics
✨🔝
Top Questions
🐦🦠
H5N1 Bird Flu
🕊️🌐
Global Elections
⏳🌀
5 Years After AGI
🇮🇱🇵🇸
Gaza Conflict
🦠🩺
Mpox outbreak
🇺🇦⚔️
Ukraine Conflict
categories
🤖
Artificial Intelligence
🧬
Health & Pandemics
🌎
Environment & Climate
☣️
Nuclear Technology & Risks
See all categories
  • About
  • API
  • FAQ
  • forecasting resources
  • For Journalists
  • Contact
  • Careers
GuidelinesPrivacy PolicyTerms of Use
ForbesScientific AmericanTimeVoxYale NewsNature

Will the 2020 U.S. Dietary Guidelines start recommending a low carbohydrate diet as an option?

resultNo

Will semaglutide be a top 300 medicine in America before 2032?

resultYes

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

3%chance

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

80%chance

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

62%chance

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

43%chance

Will tirzepatide be approved for the treatment of obesity by the FDA or EMA before 2025?

resultYes

Will bimagrumab be approved for the treatment of obesity by the FDA or EMA by 2029?

31%chance

When will the FDA or EMA first approve a drug for the treatment of obesity that causes >15% weight loss?

result08 Nov 2023 12:00

When will the FDA or EMA first approve a drug for the treatment of obesity that causes >25% weight loss?

07 Dec 2028